NDAINTRAVENOUSPOWDER
Approved
Oct 2022
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Mechanism of Action
12.1 Mechanism of Action Cefazolin is an antibacterial drug [see ] . 12.2 Pharmacodynamics The pharmacokinetic/pharmacodynamic relationship for cefazolin has not been evaluated in patients. 12.3 Pharmacokinetics Studies have shown that following intravenous administration of cefazolin for injection…
Indications (26)
respiratory tract infections due to Streptococcus pneumoniaeKlebsiella speciesHemophilus influenzaeStaphylococcus aureus (methicillin-susceptible)Group A beta-hemolytic streptococciin adultsolder for whom appropriate dosing with this formulation can be achieved [seeurinary tract infections due to Escherichia coliProteus mirabilisKlebsiella species (sppskinskin structure infections due to Sbiliary tract infections due to Ebonejoint infections due to Sgenital infections (isepticemia due to Sendocarditis due to Ssurgical patients in whom infection at the operative site would present a serious risk (eincidence of certain postoperative infections in patients undergoing surgical procedures which are classifiedpotentially contaminated (edevelopment of drug-resistant bacteriamaintain the effectiveness of Cefazolin for Injectionother antibacterial drugsCefazolin for Injection should be used only to treatprevent infectionsstrongly suspected to be caused by susceptible bacteria
Clinical Trials (1)
Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis
Started Nov 2012